FDA’s Revocation of Mutual Recognition Regulations

Gain comprehensive insights into the FDA’s proposed rule to revoke regulations on mutual recognition of pharmaceutical and medical device reports with the European Community. Learn about the impact of the 2017 Amended Pharmaceutical Annex, reasons for revocation, and implications for industry practices.

In this course you will learn the following:
* Understand the purpose and intent behind the proposed revocation of part 26.
* Recognize the major provisions and legal authority of the proposed rule.
* Identify the potential impacts and benefits of the rule change.